Diary - News
All news MaaT Pharma selected for the next Big Booster
MaaT Pharma, which develops the first treatment using an autologous intestinal microbiota transplant, has successfully reached second milestone of Big Booster, the first international non-profit acceleration program organized jointly by Boston (USA) and Lyon (France). After a 3-day boot camp in Lyon, on October 27-29, MaaT Pharma has been selected among 72 participants to be featured in the top-20 European start-ups that will participate to a second boot camp in Boston in February 2016.
